Only in vitro interaction studies are available. In these,<unk>  used the concentrative nucleoside transporter 1 (CNT1) and equilibrative nucleoside transporters 1 (ENT1) and 2 (ENT2), and<unk>  was transported by the solute carrier proteins SLC22A2 and SLC47A1. Drugs that interact with these transporters could influence blood plasma concentrations of<unk>  and<unk> .<unk> , being a thymidine phosphorylase inhibitor, could also interact with substrates of this enzyme such as zidovudine.
Trifluridine/tipiracil
Decitabine/cedazuridine
Tegafur/gimeracil/oteracil
Trastuzumab/hyaluronidase
Bortezomib/dexamethasone
Trastuzumab emtansine
Daunorubicin/cytarabine
Decitabine